NCT05252351 (CAS) is a clinical trial in Congenital Aortic Stenosis, sponsored by Erasmus Medical Center.

Who is sponsoring NCT05252351?

NCT05252351 is sponsored by Erasmus Medical Center.

What condition does NCT05252351 study?

NCT05252351 studies Congenital Aortic Stenosis.

Is NCT05252351 still recruiting?

NCT05252351 is currently active, enrolled. Last updated 12 March 2024.

Last reviewed 2024-03-12 · How we verify

NCT05252351: CAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardiac Imaging in Adults With Congenital Aortic Stenosis

Active, enrolled Last updated 12 March 2024

What this trial tests

trial in Congenital Aortic Stenosis in 75 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

13 January 2022

Primary endpoint
1 November 2026

1 November 2026

Quick facts

Lead sponsor	Erasmus Medical Center
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	75
Start date	13 January 2022
Primary completion	1 November 2026
Estimated completion	1 November 2026
Sites	1 location across Netherlands

Conditions studied

Congenital Aortic Stenosis — all drugs for Congenital Aortic Stenosis →

Sponsor

Erasmus Medical Center

Who can join

18 and older, any sex, with Congenital Aortic Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The CAS study is a prospective observational cohort study investigating the effects of congenital aortic stenosis (ConAoS) on the left ventricular function and the prevalence, pattern and expanse of left ventricular hypertrophy (LVH), myocardial stiffness and myocardial fibrosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Erasmus Medical Center trials

Trials by the same sponsor.

NCT07406269 — Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery · NA · not yet recruiting
NCT07402109 — CBCT Guided Markerless SBRT for Renal Cell Cancer · NA · recruiting
NCT07383194 — Prediction Models for LDLT Outcomes · not yet recruiting
NCT07426575 — Evaluating the Usability of New Dialysis Bags · not yet recruiting
NCT07329296 — The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05252351 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Erasmus Medical Center
Last refreshed: 12 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05252351.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing